Trial Information
Inclusion Criteria:
1. completely resected non small cell lung cancer
2. no prior anti cancer treatment for thoracic malignancy exept for this operation
3. pathological stage IB, II, and stage IIIA with only one station of n2 disease
4. PS 0-1
5. age 20-75
6. adequate organ function for chemotherapy
7. written informed consent
Exclusion Criteria:
1. small cell lung cancer or low grade malignancy of lung cancer
2. incomplete resection
3. apparent interstitial pneumonitis at chest rentogenogram
4. inadequate condition for chemotherapy
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
5 year survival rate
Principal Investigator
Hirohito Tada, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
West Japan Thoracic Oncology Group
Authority:
Japan: Ministry of Health, Labor and Welfare
Study ID:
WJTOG0101
NCT ID:
NCT00139971
Start Date:
December 2001
Completion Date:
Related Keywords:
- Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms